Q2 2026 BICO Group AB Earnings Call Transcript
Key Points
- BICO Group AB (CLLKF) reported a 7% organic sales growth in local currencies, driven by strong demand for benchtop instruments and a 10% increase in consumables sales.
- Adjusted EBITDA margin improved significantly to 6% from negative 2.6% in the prior year, reflecting successful commercial and operational excellence initiatives.
- The company's gross profit margin expanded substantially to 59% from 44% in Q2 last year, aided by a favorable product mix and a higher share of direct sales.
- BICO Group AB (CLLKF) secured a major long-term supply and license agreement with a current customer, valued at approximately EUR50 million over a 10-year term, which will boost Q3 revenue.
- The company's balance sheet remains strong with net cash of SEK207 million and cash reserves of SEK628 million, providing a solid foundation for future investments and potential acquisitions.
- BICO Group AB (CLLKF) launched innovative products like dPure and Confluent AI, which enhance lab automation and reproducibility, positioning the company to benefit from AI-driven demand in wet labs.
- BICO Group AB (CLLKF) continues to face challenges in its project-based integrated lab automation business, with execution issues and lower demand as legacy projects near completion.
- The company experienced negative cash flow from operating activities of SEK53 million, primarily due to a SEK54 million negative impact from changes in working capital.
- North American sales declined due to soft academic funding and longer lead times for larger automation investments, creating uncertainty in sales cycles.
- The academic end market remains weak, particularly in the US, due to reduced funding and delays in NIH payments, which continues to pressure demand for commodity products.
- BICO Group AB (CLLKF) is undergoing a leadership transition, with CEO Maria Forss stepping down and Anders Fogelberg taking over, which could introduce short-term strategic uncertainty.
- The company is incurring restructuring costs, including a SEK4.5 million provision for its US-based project business, as it reassesses its position in the integrated lab automation market.
Thank you, everyone, for joining us today. It's a great pleasure to be here. My name is Erik Gatenholm, and I am here today in my power as Chairman of the Board. We will spend the first minutes of this earnings call to comment on the press release published yesterday evening regarding the leadership transition. We will then proceed with the BICO Group Q2 earnings call.
Today, I have the pleasure of having Maria Force, CEO. Ival Linsatter, CFO, and Anders Fogelbeig, current CCO and incoming CEO in the call. The purpose of my remarks is to provide the Board of Directors' perspective on yesterday's announced leadership transition.
After constructive discussions together with Maria Force, the Board of Directors concluded that this is the right time for leadership change as BICO enters its next phase of development with amplified focus on commercialization, customer engagement, and profitable growth.
The Board is pleased to appoint Anders Fogelberg as President and CEO effective September 1st. As Chief Commercial Officer and a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
